company-logo

Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia; and BEAM-301, a liver-targeted development candidate for the treatment of patients with Glycogen Storage Disease Type Ia. It also develops therapies for alpha-1 antitrypsin deficiency; ocular diseases; and other liver, muscle, and central nervous system disorders. The company has an alliance with Boston Children's Hospital; a research and clinical trial collaboration agreement with Magenta Therapeutics, Inc.; license agreement with Sana Biotechnology, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration agreement with Pfizer Inc. and Apellis Pharmaceuticals, Inc.; and collaboration and license agreement with Verve Therapeutics, Inc. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.

Beam Therapeutics Dividend Announcement

Beam Therapeutics announced a quarterly dividend of $0.23 per ordinary share which will be made payable on 2014-03-03. Ex dividend date: 2014-02-04
Beam Therapeutics's trailing twelve-month (TTM) dividend yield is -%

Beam Therapeutics Dividend History

Ex-Div dateDividend amountDividend typePay date
2014-02-04$0.23quarterly2014-03-03
2013-11-04$0.23quarterly2013-12-02
2013-08-12$0.23quarterly2013-09-03
2013-05-06$0.23quarterly2013-06-03
2013-02-04$0.23quarterly2013-03-01
2012-11-05$0.21quarterly2012-12-03
2012-08-06$0.21quarterly2012-09-04
2012-05-07$0.21quarterly2012-06-01
2012-02-06$0.21quarterly2012-03-01
2011-11-07$0.19quarterly2011-12-01

Beam Therapeutics Dividend per year

Beam Therapeutics Dividend growth

Beam Therapeutics Dividend Yield

Beam Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Beam Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Beam Therapeutics Financial Ratios

P/E ratio-17.42
PEG ratio0.68
P/B ratio3.16
ROE-16.22%
Payout ratio0.00%
Current ratio5.69
Quick ratio5.69
Cash Ratio1.38

Beam Therapeutics Dividend FAQ

How much is the next Beam Therapeutics dividend?
Beam Therapeutics's board of directors will review the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the next Beam Therapeutics dividend. The next Beam Therapeutics dividend will be released in February, May, August, or November.
When is Beam Therapeutics dividend paid?
Beam Therapeutics pays dividends on a quarterly basis. The specific dates may vary each year but are generally around February, May, August, and November. However, please note that the exact timing and amount can vary, and companies may also decide to change their dividend policy based on their financial health and other considerations.
What dividend does Beam Therapeutics pay?
The specific amount of Beam Therapeutics dividend can vary from quarter to quarter and year to year, based on a variety of factors including the company's financial performance, the global economic situation, and the decisions of its board of directors. In the above table you can find Beam Therapeutics's dividend history.
Does Beam Therapeutics stock pay dividends?
Yes, Beam Therapeutics does pay dividends to its shareholders. However, the specific amount and frequency of these dividends can vary based on a variety of factors, including the company's financial performance, the global economic situation, and the decisions of its board of directors. In the above table you can find Beam Therapeutics's dividend history.
How much dividend does Beam Therapeutics pay?
Beam Therapeutics paid $0.0 in 2024, $0.0 in 2023, $0.0 in 2022, $0.0 in 2021, and $0.0 in 2020.
How often does Beam Therapeutics pay dividends?
Beam Therapeutics typically pays dividends on a quarterly basis. This means that dividends are usually distributed 4 times a year. The specific payout dates may vary each year but generally fall around February, May, August, and November.
What is Beam Therapeutics's dividend yield?
The current dividend yield for Beam Therapeutics is -%. The dividend yield is calculated by dividing the annual dividend payment by the price of the stock. Both of these numbers can fluctuate daily due to changes in the stock price and any updates to the dividend payment. Use the dividend calculator on this page to calculate Beam Therapeutics's exact dividend yield.
When does Beam Therapeutics go ex dividend?
Beam Therapeutics's ex-dividend date for the latest dividend was on 2014-02-04. Beam Therapeutics typically goes ex-dividend a few weeks before the payment date. The specific dates can vary each year and for each dividend payment.
When is the next Beam Therapeutics dividend paid?
Beam Therapeutics pays dividends on a quarterly basis, typically around February, May, August, or November, but the exact dates can vary each year.
Will Beam Therapeutics increase its dividend?
Decisions about dividend payments are made by the company's board of directors and are based on a variety of factors. To understand whether Beam Therapeutics will increase its dividend, it's beneficial to look at the company's earnings, financial health, future business prospects, and the overall economic environment.
How much is Beam Therapeutics dividend per share?
Beam Therapeutics paid $0.0 per share in 2024 and $0.0 per share in 2023. The amount of dividend per share that Beam Therapeutics pays can vary each quarter based on a range of factors including the company's earnings, financial health, and decisions made by its board of directors.
Is Beam Therapeutics a dividend aristocrat?
No, the term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Beam Therapeutics a dividend king?
No, a "Dividend King" is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Beam Therapeutics a dividend stock?
Yes, Beam Therapeutics is considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
Is Beam Therapeutics a good dividend stock?
Whether Beam Therapeutics is a good dividend stock depends on several factors and can vary depending on individual investment goals, risk tolerance, and the overall market conditions. Beam Therapeutics has a history of paying regular dividends, which can make it attractive to income-focused investors.

Other factors to consider when evaluating Beam Therapeutics as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Does Beam Therapeutics pay dividends monthly?
Beam Therapeutics typically pays dividends on a quarterly basis.
Does Beam Therapeutics pay dividends quarterly?
Beam Therapeutics currently pays dividends on a quarterly basis.
Has Beam Therapeutics ever paid a dividend?
Yes, Beam Therapeutics has a history of paying dividends to its shareholders. Beam Therapeutics is known for its dividend payments, which have made it an attractive investment for income-focused investors.
How to buy Beam Therapeutics dividend stocks?
To buy Beam Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees, account minimums, and the availability of dividend reinvestment programs (DRIPs) if you wish to reinvest your dividends automatically.

Place an order: Use the brokerage's trading platform to place an order to buy Beam Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
When does Beam Therapeutics pay dividends 2024?
Beam Therapeutics pays dividends on a quarterly basis. 2024 dividend payments are in 2014-03-03. However, please note that the exact timing and amount can vary, and companies may also decide to change their dividend policy based on their financial health and other considerations.
Will Beam Therapeutics increase its dividend in 2024?
Decisions regarding Beam Therapeutics dividend increases are typically made by a company's board of directors based on various factors, including financial performance, cash flow, investment needs, and market conditions. For an up-to-date Beam Therapeutics dividend overview you can look into the above table of dividend history.
How Beam Therapeutics dividend works?
The Beam Therapeutics dividend works by distributing a portion of the company's profits to its shareholders on a per-share basis. Here's a general overview of how Beam Therapeutics's dividend process works:

1. Determination of Dividend: Beam Therapeutics's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.

2. Dividend Declaration: Once the board approves a dividend, Beam Therapeutics publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.

3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.

4. Payment Date: On the designated payment date, Beam Therapeutics distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.

5. Tax Implications: Dividends received from Beam Therapeutics are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
How are Beam Therapeutics dividends paid?
Beam Therapeutics dividends are typically paid in cash directly to eligible shareholders. The payment process involves the following steps:

1. Record Date: Beam Therapeutics sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.

2. Payment Date: On the designated payment date, Beam Therapeutics distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.

3. Currency: Beam Therapeutics declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
How many times does Beam Therapeutics pay dividends?
Beam Therapeutics typically pays dividends on a quarterly basis. The specific payment dates can vary each year and are usually announced when the company releases its financial results for each quarter.
What months does Beam Therapeutics pay dividends?
The general pattern is that Beam Therapeutics pays dividends around February, May, August, and November. However, the exact payment dates can vary each year and are typically announced when the company releases its financial results for each quarter.
Is Beam Therapeutics dividend safe?
The safety of Beam Therapeutics's dividend is subject to various factors and cannot be determined with certainty. It is influenced by the company's financial performance, cash flow, and the overall economic and industry conditions.

To assess the safety of Beam Therapeutics's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.

It is recommended to review Beam Therapeutics's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.